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Dr. Benach questioned whether the relationship between HLA-DR2 and Lyme
disease has held up. Dr. Steere responded that additional patients have been tested
since the initial report in 1979. It seems mainlythat patients with neurologic involve-
ment, arthritis or chronic arthritis, have an increased frequency of HLA-DR2. As
yet, HLA phenotypes have not been determined for European patients.
Dr. Edelman asked whether lymphocytoma benigna cutis and acrodermatitis
chronica atrophicans are clinical variants ofECM that are only seen in Europe. Dr.
Weber stated that both lymphocytoma and acrodermatitis have been described in
the U.S.A.; the latter lesion has been seen primarily in patients who immigrated
from Europe. Lymphocytoma is probably a non-specific reaction that may have
more than one etiology. Dr. Steere questioned Dr. Weber on the frequency of tick
bites in patients with lymphocytoma. Dr. Weber stated that tick bites were occa-
sionally observed; in one out of four patients, a tick was removed from an ear lobe
where lymphocytoma developed. Acrodermatitis was found by Walter Hauser to
have the same distribution as Ixodes ricinus in Europe. Acrodermatitis atrophicans
is thus probably a sequela of spirochetal infection. Dr. Stenn added that both acro-
dermatitis and lymphocytoma have been seen in patients presenting to the dermato-
pathology department at Yale.
Drs. Verardo and Shope asked about the efficacy of antibiotics in treating Lyme
disease and whether antibiotic prophylaxis should be employed for individuals en-
tering an endemic area. Dr. Steere answered that antibiotic therapy early in the
course of Lyme disease is clearly effective. It seems that later therapy is also effec-
tive, but higher doses of antibiotics may be required. Therefore, Dr. Steere did not
recommend the prophylactic approach. Dr. Paardenkooper mentioned that he
nevertheless goes ahead and treats individuals from an endemic area with a clear
history of tick bite.
Dr. Bartenhagen asked if Lyme disease takes a milder course in European pa-
tients. Dr. Steere agreed that there were some differences between American and
European cases ofLyme disease. The multiple secondary annular skin lesions, com-
mon in the United States, seem much less common in European patients. Although
patients in Europe may develop arthralgias or arthritis, joint involvement seems to
be much more prominent in patients seen in the United States.
Dr. Shulman inquired about future research avenues in deciphering the patho-
genesis of Lyme arthritis. Dr. Malawista suggested that one question is whether the
arthritis is related to alive or adead organism. Ifantibiotics curethe arthritis, then a
live organism is clearly involved, although not necessarily one that resides injoints;
it is possible that the organism simply contributes a poorly degradable substance
that drives the inflammation. The approach here is to search for the organism and
antigens related to it in tissues. It is hoped that methods developed for these pur-
poses in Lyme disease, where an agent andits antigens are now known, will be useful
for the study of other rheumatic diseases of unknown etiology.
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